Biora Therapeutics Revenue and Competitors

0, CA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Biora Therapeutics's estimated annual revenue is currently $10.4M per year.(i)
  • Biora Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Biora Therapeutics has 67 Employees.(i)
  • Biora Therapeutics grew their employee count by 0% last year.

Biora Therapeutics's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
VP Human ResourcesReveal Email/Phone
4
SVP Technical OperationsReveal Email/Phone
5
Senior Director Corporate Controller Reveal Email/Phone
6
Director, Financial ReportingReveal Email/Phone
7
Sr. Director FP&AReveal Email/Phone
8
Director Translational MedicineReveal Email/Phone
9
Director Clinical and Translational ScienceReveal Email/Phone
10
Associate Director Device DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Biora Therapeutics?

Biora Therapeutics is reimagining therapeutics by creating smart pills designed for - targeted drug delivery to the GI tract, and - systemic, needle-free delivery of biotherapeutics we are developing therapies to improve patients’ lives. At Biora, we envision a world where patients have access to needle-free drug delivery and better therapeutic outcomes. We welcome you to learn more about our mission and our guiding principles at https://bioratherapeutics.com/company/about

keywords:N/A

N/A

Total Funding

67

Number of Employees

$10.4M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.7M6710%N/A
#2
$8.7M67N/AN/A
#3
$8.7M67N/AN/A
#4
$19.9M67-7%N/A
#5
$19.9M67-14%$69M